I am a
Home I AM A Search Login

Papers of the Week


2020


PLoS One


15


1

Predictive factors of first dosage intravenous immunoglobulin-related adverse effects in children.

Authors

Kubota J, Hamano S-I, Daida A, Hiwatari E, Ikemoto S, Hirata Y, Matsuura R, Hirano D
PLoS One. 2020; 15(1):e0227796.
PMID: 31929600.

Abstract

Intravenous immunoglobulin (IVIG) therapy is used in the treatment of various diseases, and IVIG-related adverse effects (IVIG-AEs) vary from mild to severe. However, the mechanisms underlying IVIG-AEs and the potential predictive factors are not clear. This study investigated whether certain IVIG-AEs can be predicted before IVIG administration.